Julia Letlow wants Louisiana's open Senate seat badly enough to debate John Fleming on the Moon Griffon Show and trade attack ads about who loves Trump more. The New York Times is tracking her polls. NOLA.com is covering her spats. And while all that campaign noise fills the air, her financial disclosure record has been quietly filling up too: 17 trades in the last 90 days, spread across energy, insurance, biotech, real estate, and tech.
The Portfolio, Briefly
Per her disclosure record on Blind Trust, Letlow filed 15 trades across three dates in a single ten-day window in February 2026. Each transaction is in the $1,000–$15,000 range, so the dollar amounts are modest. The breadth is what catches the eye.
- Sold: HF Sinclair (DINO), Intercontinental Exchange (ICE), Broadcom (AVGO), ICON Plc (ICLR), AT&T (T), Take-Two Interactive (TTWO), Public Service Enterprise Group (PEG), Expand Energy (EXE), Humana (HUM), BXP Inc. (BXP)
- Bought: Vistra Corp (VST), Extra Space Storage (EXR), Travelers Companies (TRV), Meta Platforms (META), Regeneron Pharmaceuticals (REGN)
Ten sells and five buys. She rotated out of a downstream oil refiner, a health insurer, a financial exchange, a telecom giant, and a video game company. She rotated into a power generator, a self-storage REIT, an insurer, a social media platform, and a biotech.
The Energy Angle
Letlow sits on the House Energy and Commerce Committee. That's a fact, not an accusation. It's also a fact that several names on her trade list fall squarely inside that committee's jurisdiction.
She sold HF Sinclair, an oil refiner that regularly surfaces in energy policy debates. She sold Public Service Enterprise Group, a major regulated utility. She sold Expand Energy, a natural gas producer. Then she bought Vistra Corp, one of the largest independent power producers in the country, positioned at the intersection of fossil fuel generation, nuclear, and data center electricity demand.
The sell-the-old-energy, buy-the-new-energy pattern might reflect nothing more than a financial adviser's sector-rotation call. Vistra has been one of the best-performing power stocks of the past two years. It's a popular trade. The question the filings raise, and leave unanswered, is whether a member with a front-row seat to energy legislation sees the same data the rest of us see — or more of it.
Members are required to disclose. They are not required to divest, recuse, abstain, or even acknowledge the overlap. That's the rule.
The Health Care Moves
She sold Humana on February 10. She sold ICON Plc, a clinical research organization, on February 12. She bought Regeneron Pharmaceuticals on February 12.
Humana had already been under pressure for months, battered by Medicare Advantage reimbursement cuts and rising medical costs — selling it in early February wasn't a contrarian call. Pairing that sale with a Regeneron buy shows a specific thesis about where health care value is moving: out of managed care, into high-margin biotech whose fortunes turn on FDA approvals and drug pricing policy. Letlow sits in a Congress currently debating Medicaid cuts and drug pricing provisions in the reconciliation package. The thesis could be purely financial. It could be informed. The filings don't say.
The Senate Race Context
Letlow is running to leave the House. If she wins, she vacates her House seat and her committee assignments evaporate. If she loses, she returns to Energy and Commerce with a portfolio she just reshuffled.
Either way, she filed 17 trades in 90 days while holding debates, cutting ads, and barnstorming Louisiana. The campaign's public argument is about who's the better Trump ally. The financial filings are making a quieter argument about something else entirely.
The receipts are public. Make of them what you make of them.